Construction of Active Sites-Accessible Au8 Clusters for Intensive Tumor Pyroptosis

Qiu-Xu Zang , Wei-Tong Chen , Wenjing Zhang , Zhao-Yang Wang , Xi-Yan Dong , Runping Han , Yanjuan Sang , Xiaoyuan Chen , Shuang-Quan Zang

Aggregate ›› 2025, Vol. 6 ›› Issue (6) : e70046

PDF
Aggregate ›› 2025, Vol. 6 ›› Issue (6) :e70046 DOI: 10.1002/agt2.70046
RESEARCH ARTICLE

Construction of Active Sites-Accessible Au8 Clusters for Intensive Tumor Pyroptosis

Author information +
History +
PDF

Abstract

Atomically precise gold nanoclusters (NCs), possessing characteristics of molecules and nanoparticles, offer a promising solution to the challenges faced by existing pyroptosis inducers. Their abilities to catalyze the generation of reactive oxygen species and enhance radiosensitization position them as effective agents for activating pyroptosis. However, their catalytic efficiency is often compromised by limited geometrically accessible spaces around the active sites and the lack of suitable ligands. Leveraging the exposed metal centers in mononuclear organometallic catalysts and the tunable ligand of NCs, herein, ethynylferrocene (EFc) was utilized to amplify the peroxidase (POD)-like activity of gold NCs by establishing the unshielded catalytic center and electron donor-acceptor interaction between EFc and Au core. The resulting Au8Fe2 NCs with excellent POD-mimicking activity could efficiently trigger pyroptosis by inducing intracellular oxidative stress. Moreover, the Au8Fe2 NCs, with their potential to deplete glutathione and enable magnetic resonance imaging, could also induce ferroptosis and serve as a diagnostic tool for tumors. All of these processes can be further potentiated by X-ray radiation, taking advantage of the high atomic number of gold. This work opens new avenues for engineering the catalytic properties of NCs and broadens their potential applications in biomedicine.

Keywords

catalytic performance / ferrocene / gold nanocluster / ligand engineering / pyroptosis

Cite this article

Download citation ▾
Qiu-Xu Zang, Wei-Tong Chen, Wenjing Zhang, Zhao-Yang Wang, Xi-Yan Dong, Runping Han, Yanjuan Sang, Xiaoyuan Chen, Shuang-Quan Zang. Construction of Active Sites-Accessible Au8 Clusters for Intensive Tumor Pyroptosis. Aggregate, 2025, 6(6): e70046 DOI:10.1002/agt2.70046

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

D. Wu, S. Wang, G. Yu, and X. Chen, “Cell Death Mediated by the Pyroptosis Pathway With the Aid of Nanotechnology: Prospects for Cancer Therapy,” Angewandte Chemie International Edition 60 (2020): 8018-8034.

[2]

J. Shi, Y. Zhao, K. Wang, et al., “Cleavage of GSDMD by Inflammatory Caspases Determines Pyroptotic Cell Death,” Nature 526 (2015): 660-665.

[3]

B. Chen, Y. Yan, Y. Yang, et al., “A Pyroptosis Nanotuner for Cancer Therapy,” Nature Nanotechnology 17 (2022): 788-798.

[4]

Y. Chen, W. Li, S. Kwon, Y. Wang, Z. Li, and Q. Hu, “Small-Molecule Ferritin Degrader as a Pyroptosis Inducer,” Journal of the American Chemical Society 145 (2023): 9815-9824.

[5]

Y. Wang, W. Gao, X. Shi, et al., “Chemotherapy Drugs Induce Pyroptosis Through Caspase-3 Cleavage of a Gasdermin,” Nature 547 (2017): 99-103.

[6]

M. Wu, X. Liu, H. Chen, et al., “Activation of Pyroptosis by Membrane-Anchoring AIE Photosensitizer Design: New Prospect for Photodynamic Cancer Cell Ablation,” Angewandte Chemie International Edition 60 (2021): 9093-9098.

[7]

S. Zhang, Y. Zhang, Y. Feng, et al., “Biomineralized Two-Enzyme Nanoparticles Regulate Tumor Glycometabolism Inducing Tumor Cell Pyroptosis and Robust Antitumor Immunotherapy,” Advanced Materials 34 (2022): 2206851.

[8]

W. Zhang, Z. Liu, J. Zhu, et al., “Bioorthogonal Disruption of Pyroptosis Checkpoint for High-Efficiency Pyroptosis Cancer Therapy,” Journal of the American Chemical Society 145 (2023): 16658-16668.

[9]

L. Yu, Y. Xu, Z. Pu, et al., “Photocatalytic Superoxide Radical Generator That Induces Pyroptosis in Cancer Cells,” Journal of the American Chemical Society 144 (2022): 11326-11337.

[10]

Z. Zhou, R. Yang, J. Dong, et al., “Pore Forming-Mediated Intracellular Protein Delivery for Enhanced Cancer Immunotherapy,” Science Advances 8 (2022): eabq4659.

[11]

L. Zhang, A. Song, Q.-C. Yang, et al., “Integration of AIEgens Into Covalent Organic Frameworks for Pyroptosis and Ferroptosis Primed Cancer Immunotherapy,” Nature Communications 14 (2023): 5355.

[12]

X.-Q. Zhou, P. Wang, V. Ramu, et al., “In Vivo Metallophilic Self-Assembly of a Light-Activated Anticancer Drug,” Nature Chemistry 15 (2023): 980-987.

[13]

X.-M. Luo, Y.-K. Li, X.-Y. Dong, and S.-Q. Zang, “Platonic and Archimedean Solids in Discrete Metal-Containing Clusters,” Chemical Society Reviews 52 (2023): 383-444.

[14]

Y. Shi, Z. Wu, M. Qi, et al., “Multiscale Bioresponses of Metal Nanoclusters,” Advanced Materials 36 (2024): 2310529.

[15]

K. Xiao, Y. Xue, B. Yang, and L. Zhao, “Encapsulation and Regeneration of Perovskite Film by In Situ Forming Cobalt Porphyrin Polymer for Efficient Photovoltaics,” CCS Chemistry 2 (2020): 488-494.

[16]

S. Zhang, Y. Li, L. Feng, et al., “Octagold Selenido Nanoclusters: Significance of Surface Ligands on Tuning Geometric and Electronic Structure of Au8Se2 Kernel,” Nano Research 14 (2021): 3343-3351.

[17]

W.-D. Tian, W.-D. Si, S. Havenridge, et al., “Biomimetic Crystallization for Long-Pursued -COOH-Functionalized Gold Nanocluster With Near-Infrared Phosphorescence,” Science Bulletin 69 (2024): 40-48.

[18]

Y. Hua, J.-H. Huang, Z.-H. Shao, et al., “Composition-Dependent Enzyme Mimicking Activity and Radiosensitizing Effect of Bimetallic Clusters to Modulate Tumor Hypoxia for Enhanced Cancer Therapy,” Advanced Materials 34 (2022): e2203734.

[19]

G. Yang, Z. Wang, F. Du, F. Jiang, X. Yuan, and J. Y. Ying, “Ultrasmall Coinage Metal Nanoclusters as Promising Theranostic Probes for Biomedical Applications,” Journal of the American Chemical Society 145 (2023): 11879-11898.

[20]

Y.-M. Xie, Y. Wang, G. Zhang, et al., “Ligand-Targeted Ag 9 Cluster Self-Cascade Antioxidants for Enhanced Reactive Oxygen Species Clearance in the Treatment of Inflammatory Bowel Disease,” Nano Letters 25 (2025): 2960-2967.

[21]

H. Shan, J. Shi, T. Chen, et al., “Modulating Catalytic Activity and Stability of Atomically Precise Gold Nanoclusters as Peroxidase Mimics via Ligand Engineering,” ACS Nano 17 (2023): 2368-2377.

[22]

G. Yang, X. Pan, W. Feng, et al., “Engineering Au 44 Nanoclusters for NIR-II Luminescence Imaging-Guided Photoactivatable Cancer Immunotherapy,” ACS Nano 17 (2023): 15605-15614.

[23]

H. Liu, Y. Li, S. Sun, et al., “Catalytically Potent and Selective Clusterzymes for Modulation of Neuroinflammation Through Single-Atom Substitutions,” Nature Communications 12 (2021): 114.

[24]

Z. J. Guan, J. J. Li, F. Hu, and Q. M. Wang, “Structural Engineering Toward Gold Nanocluster Catalysis,” Angewandte Chemie International Edition 61 (2022): e202209725.

[25]

S. Hossain, Y. Niihori, L. V. Nair, B. Kumar, W. Kurashige, and Y. Negishi, “Alloy Clusters: Precise Synthesis and Mixing Effects,” Accounts of Chemical Research 51 (2018): 3114-3124.

[26]

X. Liu, E. Wang, M. Zhou, et al., “Asymmetrically Doping a Platinum Atom Into a Au 38 Nanocluster for Changing the Electron Configuration and Reactivity in Electrocatalysis,” Angewandte Chemie International Edition 61 (2022): e202207685.

[27]

K. Peng, Y. Zheng, W. Xia, and Z.-W. Mao, “Organometallic Anti-Tumor Agents: Targeting From Biomolecules to Dynamic Bioprocesses,” Chemical Society Reviews 52 (2023): 2790-2832.

[28]

R. Jazzar, M. Soleilhavoup, and G. Bertrand, “Cyclic (Alkyl)- and (Aryl)-(Amino)Carbene Coinage Metal Complexes and Their Applications,” Chemical Reviews 120 (2020): 4141-4168.

[29]

C. Copéret, “Fuels and Energy Carriers From Single-Site Catalysts Prepared via Surface Organometallic Chemistry,” Nature Energy 4 (2019): 1018-1024.

[30]

H. Shen, Q. Wu, S. Malola, et al., “N-Heterocyclic Carbene-Stabilized Gold Nanoclusters With Organometallic Motifs for Promoting Catalysis,” Journal of the American Chemical Society 144 (2022): 10844-10853.

[31]

R. Pietschnig, “Polymers With Pendant Ferrocenes,” Chemical Society Reviews 45 (2016): 5216-5231.

[32]

L. Zhang, H. Chen, X. Zhao, et al., “The Marriage of Ferrocene and Silicotungstate: An Ingenious Heterogeneous Fenton-Like Synergistic Photocatalyst,” Applied Catalysis B Environment and Energy 193 (2016): 47-57.

[33]

J.-Q. Wang, R.-L. He, W.-D. Liu, et al., “Integration of Metal Catalysis and Organocatalysis in a Metal Nanocluster With Anchored Proline,” Journal of the American Chemical Society 145 (2023): 12255-12263.

[34]

J. Wang, H. Ding, Y. Zhu, et al., “Iron-siRNA Nanohybrids for Enhanced Chemodynamic Therapy via Ferritin Heavy Chain Downregulation,” Angewandte Chemie International Edition 62 (2023): e202302255.

[35]

C. Ji, H. Li, L. Zhang, et al., “Ferrocene-Containing Nucleic Acid-Based Energy-Storage Nanoagent for Continuously Photo-Induced Oxidative Stress Amplification,” Angewandte Chemie International Edition 61 (2022): e202200237.

[36]

S. Wang, Z. Wang, and Y. Hou, “Self-Assembled Magnetic Nanomaterials: Versatile Theranostics Nanoplatforms for Cancer,” Aggregate 2 (2021): e18.

[37]

Y. Kamei, Y. Shichibu, and K. Konishi, “Generation of Small Gold Clusters With Unique Geometries Through Cluster-to-Cluster Transformations: Octanuclear Clusters With Edge-Sharing Gold Tetrahedron Motifs,” Angewandte Chemie International Edition 50 (2011): 7442-7445.

[38]

Z. Lin, N. Goswami, T. Xue, et al., “Engineering Metal Nanoclusters for Targeted Therapeutics: From Targeting Strategies to Therapeutic Applications,” Advanced Functional Materials 31 (2021): 2105662.

[39]

N. Kobayashi, Y. Kamei, Y. Shichibu, and K. Konishi, “Protonation-Induced Chromism of Pyridylethynyl-Appended [Core+ Exo]-Type Au8 Clusters. Resonance-Coupled Electronic Perturbation Through π-Conjugated Group,” Journal of the American Chemical Society 135 (2013): 16078-16081.

[40]

Y. Feng, Y. Wang, J. Zhang, et al., “Self-Assembly of Ferrocene Peptides: A Nonheme Strategy to Construct a Peroxidase Mimic,” Advanced Materials Interfaces 6 (2019): 1901082.

[41]

Q. Li, Z. Zhao, F. Chen, et al., “Delocalization Engineering of Heme-Mimetic Artificial Enzymes for Augmented Reactive Oxygen Catalysis,” Angewandte Chemie International Edition 63 (2024): e202400838.

[42]

M. Zandieh and J. Liu, “Nanozymes: Definition, Activity, and Mechanisms,” Advanced Materials 36 (2023): 2211041.

[43]

R.-H. Liu, S.-Y. Fu, H.-Y. Zhan, and L. A. Lucia, “General Spectroscopic Protocol to Obtain the Concentration of the Superoxide Anion Radical,” Industrial & Engineering Chemistry Research 48 (2009): 9331-9334.

[44]

B. Jiang, D. Duan, L. Gao, et al., “Standardized Assays for Determining the Catalytic Activity and Kinetics of Peroxidase-Like Nanozymes,” Nature Protocols 13 (2018): 1506-1520.

[45]

L. Gao, J. Zhuang, L. Nie, et al., “Intrinsic Peroxidase-Like Activity of Ferromagnetic Nanoparticles,” Nature Nanotechnology 2 (2007): 577-583.

[46]

Z. Ren, S. Sun, R. Sun, et al., “A Metal-Polyphenol-Coordinated Nanomedicine for Synergistic Cascade Cancer Chemotherapy and Chemodynamic Therapy,” Advanced Materials 32 (2019): 1906024.

[47]

Y.-J. Wang, X.-Y. Shi, P. Xing, X.-Y. Dong, and S.-Q. Zang, “Halogen Bonding-Driven Chiral Amplification of a Bimetallic Gold-Copper Cluster Through Hierarchical Assembly,” Science Advances 9 (2023): eadj9013.

[48]

T. R. Nayak, A. Chrastina, J. Valencia, et al., “Rapid Precision Targeting of Nanoparticles to Lung via Caveolae Pumping System in Endothelium,” Nature Nanotechnology 20 (2025): 144-155.

[49]

M. J. Mitchell, M. M. Billingsley, R. M. Haley, M. E. Wechsler, N. A. Peppas, and R. Langer, “Engineering Precision Nanoparticles for Drug Delivery,” Nature Reviews Drug Discovery 20 (2020): 101-124.

[50]

C. Wong, T. Stylianopoulos, J. Cui, et al., “Multistage Nanoparticle Delivery System for Deep Penetration Into Tumor Tissue,” Proceedings National Academy of Science USA 108 (2011): 2426-2431.

[51]

I. Posadas, L. Romero-Castillo, N. El Brahmi, et al., “Neutral High-Generation Phosphorus Dendrimers Inhibit Macrophage-Mediated Inflammatory Response In Vitro and In Vivo,” Proceedings National Academy of Science USA 114 (2017): E7660.

[52]

D. Trachootham, J. Alexandre, and P. Huang, “Targeting Cancer Cells by ROS-Mediated Mechanisms: A Radical Therapeutic Approach?” Nature Reviews Drug Discovery 8 (2009): 579-591.

RIGHTS & PERMISSIONS

2025 The Author(s). Aggregate published by SCUT, AIEI, and John Wiley & Sons Australia, Ltd.

AI Summary AI Mindmap
PDF

93

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/